Triphase Research and Development III Corp.
1 clinical trials · Sponsor
◉ Watch Triphase Research and Development III Corp.
| Record | Firm | Date |
|---|---|---|
| Study of TRPH-222 in Patients With Relapsed and/or Refractory B-Cell Lymphoma (NCT03682796) | Triphase Research and Development III Corp. | 2018-10-15 |
Track Triphase Research and Development III Corp. automatically
Every clearance here is in the API, with alerts when new ones post.